Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Virological Methods

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jviromet.2007.12.018PMID 18294705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model.

  2007cited by this paper
• Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.

  2007cited by this paper
• Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.

  2006cited by this paper
• Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.

  2006cited by this paper
• Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.

  2006cited by this paper
• Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99.

  2005cited by this paper
• Neutralizing Antibodies Elicited by Immunization of Monkeys with DNA Plasmids and Recombinant Adenoviral Vectors Expressing Human Immunodeficiency Virus Type 1 Proteins

  2005cited by this paper
• Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.

  2004cited by this paper
• High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

  2004cited by this paper
• Novel Viral Disease Control Strategy: Adenovirus Expressing Alpha Interferon Rapidly Protects Swine from Foot-and-Mouth Disease

  2003cited by this paper
• FMD vaccines.

  2003cited by this paper
• Molecular basis of pathogenesis of FMDV.

  2003cited by this paper
• Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure

  2003cited by this paper
• Effective synthetic peptide vaccine for foot-and-mouth disease in swine.

  2002cited by this paper
• Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice

  2002cited by this paper
• Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein.

  2002cited by this paper
• Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model1

  2002cited by this paper
• Interferons α and β as Immune Regulators—A New Look

  2001cited by this paper
• Interferons alpha and beta as immune regulators--a new look.

  2001cited by this paper
• Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

  2001cited by this paper
• Synthetic peptide vaccines: foot-and-mouth disease virus as a model.

  1999cited by this paper
• Advances in vaccine adjuvants

  1999cited by this paper
• A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants

  1997cited by this paper
• Biochemical characterization of FMDV A10 and A22 subtypes by PAGE and IEF.

  1997cited by this paper
• Induction of TH1 and TH2 Immunity in Neonatal Mice

  1996cited by this paper
• New approaches to vaccination against foot-and-mouth disease.

  1992cited by this paper
• Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

  1992cited by this paper
• Developments in foot-and-mouth disease vaccines.

  1991cited by this paper
• A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle.

  1991cited by this paper
• Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus

  1990cited by this paper
• Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

  1982cited by this paper

• Construction and evaluation of a chimeric vaccine against Clostridium perfringens type a of sika deer.

  2025cites this paper
• Epidemiological and genetic characteristics of foot-and-mouth disease virus in China from 2010 to 2022.

  2023cites this paper
• Immune Responses to Orally Administered Recombinant Lactococcus lactis Expressing Multi-Epitope Proteins Targeting M Cells of Foot-and-Mouth Disease Virus

  2021cites this paper
• Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine.

  2020cites this paper
• Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

  2020cites this paper
• LDHs enhanced the immune response of animals to foot-and-mouth disease virus

  2020cites this paper
• Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin

  2019cites this paper
• Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation

  2018cites this paper
• Design and Construction of Multiple-Epitope Recombinant Vaccine Against Foot-and-Mouth Disease Virus Type O

  2017cites this paper
• Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus

  2017cites this paper
• Immunogenicity of a recombinant adenovirus expressing porcine reproductive and respiratory syndrome virus polyepitopes.

  2017cites this paper
• A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds.

  2016cites this paper
• Adjuvants for foot-and-mouth disease virus vaccines: recent progress

  2014cites this paper
• Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.

  2014cites this paper
• Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs.

  2013cites this paper
• Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus

  2012cites this paper
• Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.

  2012cites this paper
• Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant.

  2012cites this paper
• Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.

  2012cites this paper
• Enhancement of Astragalus polysaccharide on the immune responses in pigs inoculated with foot-and-mouth disease virus vaccine.

  2011cites this paper
• Immunogenicity and protective efficacy of a replication-defective infectious bronchitis virus vaccine using an adenovirus vector and administered in ovo.

  2010cites this paper
• xpression of exogenous IFN-by bypassing the translation block protects cells gainst FMDV infection

  2009cites this paper
• Expression of exogenous IFN-alpha by bypassing the translation block protects cells against FMDV infection.

  2009cites this paper